ADXN Q1 2024 Earnings ClinicalStage Biotech Reports Net Loss as Pipeline Advances Compass Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Pipeline Progress FGSN Q1 2026 Earnings Earnings Miss Sends Notes Lower FLR Q1 2026 Earnings EPS Falls Sharply Short of Estimates Stock Edges Higher Sensei Biotherapeutics SNSE Q1 2026 Earnings Massive EPS Miss Overshadowed by Upbeat Sentiment Alumis Inc ALMS Q1 2026 Earnings Narrower Loss Mirrors Operational Discipline PreRevenue Stage Persists